Pharma Stocks

Zealand Pharma Drops 31% After Disappointing Weight Loss Drug Trial Results

Key Stats for Zealand Pharma Stock Price change for Zealand Pharma stock on Friday Mar. 06: -31% $ZLDPF Share Price…

Read More »

Kyowa Kirin (TSE:4151) Is Down 22.0% After Halting Rocatinlimab Trials Over Malignancy Concerns – Has The Bull Case Changed?

In early March 2026, Kyowa Kirin and Amgen discontinued all clinical trials of rocatinlimab after a planned safety review highlighted…

Read More »

2 Underrated Weight Loss Stocks to Buy Now

Key Points Regeneron has a pair of weight-loss candidates close to entering late-stage studies. Roche’s recent mid-stage readout positions it…

Read More »

Assessing InnoCare Pharma (SEHK:9969) Valuation After Priority Review Milestone For Zurletrectinib

InnoCare Pharma (SEHK:9969) has drawn fresh attention after China’s drug regulator granted priority review to its next generation TRK inhibitor…

Read More »

Is Sumitomo Pharma (TSE:4506) Quietly Recasting Its Investment Story Around Regenerative Medicine And GEMTESA?

In early March 2026, Sumitomo Pharma secured conditional Japanese approval for AMCHePRY, the world’s first iPS cell-derived regenerative therapy for…

Read More »

XDEMVY Growth And China Deal Reshape Tarsus Pharmaceuticals Investment Story

Tarsus Pharmaceuticals reports strong launch momentum for XDEMVY in Demodex blepharitis, supporting rapid revenue growth. The company signs an agreement…

Read More »

Zealand Pharma Weighs Petrelintide Progress Against Sharp Share Price Reset

Zealand Pharma reported positive Phase 2 topline results for petrelintide, its obesity drug candidate, with clinically meaningful weight loss and…

Read More »

Citius Pharma (CTXR) Becomes Revenue-Generating With the Commercial Launch of LYMPHIR

Citius Pharmaceuticals Inc. (NASDAQ:CTXR) is one of the stocks that should double in 3 years. On February 13, Citius Pharmaceuticals…

Read More »

Zealand stock plummets after trial setback, CEO remains optimistic

Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight management in adults…

Read More »

Helus Pharma reports HLP004 Phase 2 signal detection study results

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on study results,…

Read More »